Global Teledermatology Market Overview

Teledermatology Market Size Was Valued at USD 14.85 Billion in 2023 and is Projected to Reach USD 92.45 Billion by 2032, Growing at a CAGR of 22.53% From 2024-2032.

The history of telemedicine may be traced back to the 19th century when ship captains used radio to seek medical advice and electrocardiograms were sent via telephone lines. Teledermatology was first mentioned in the medical literature in 1993 when it became popular in Norway in fields such as radiology and pathology. Telemedicine is a modern technology that provides remote health care services. Telemedicine has been on the rise since the COVID-19 pandemic started as it eliminates the physical presence of both patients and medical professionals. Dermatology, as a visually-dependent specialty, is well-suited to this type of healthcare service. This has been proved in several recent research that emphasized teledermatology's feasibility and reliability. Many patients around the world still lack access to proper dermatological care, and skin cancer morbidity is increasing. Clinical advancements have allowed clinicians to care for a wide range of patient populations who require skin knowledge while lowering their overhead costs.

Market Dynamics and Key Factors in Teledermatology Market:

Drivers

Teledermatology can be utilized by health care workers for various applications such as providing clinical services to patients, monitoring patient health, consulting with other health care practitioners, and providing patients with educational resources. Teledermatology is the best solution to issues concerning cancer diagnosis, screening, and treatment, as well as pigmented skin lesions. Teledermatology is the most convenient option for the geriatric population as in old age it becomes difficult for them to visit clinics. The growing geriatric population across the globe will create more demand for dermatologists in years to come. According to a study conducted in São Paulo, Brazil, teledermatology managed 66.66% of the total participants (age above 60) without the need for an in-presence visit.

Improved telecommunication infrastructure in developing nations is another driving factor for the teledermatology market. The major investments in 4G LTE networks that these countries are planning to implement will boost the teledermatological market. This will enable a doctor in the United States, or even in another country's urban region, to treat patients in rural areas remotely. Due to an increase in the incidence of skin disorders such as skin cancer, eczema, and psoriasis, the number of dermatological services has increased significantly. According to the American Association of Dermatology, around 50 million Americans have acne, 30 million have eczema, and 7.5 million have psoriasis. Every day, around 9,500 people in the United States are diagnosed with skin cancer. Thereby, the growing number of skin disorders around the globe is expected to strengthen the growth of the teledermatology market over the analysis period.

Restraints:

The most serious concern about online consultations has been the accuracy of diagnosis. Poor-quality photographs shared by the patient might reduce diagnosis accuracy and increase errors drastically. Untrained individuals may not know which lesions to photograph, how to picture them, or may choose to overlook private parts, oral mucosa, and other areas. It's also tough to photograph places that aren't easily accessible to the patient, such as the back, buttocks, and scalp. All these factors can affect the diagnosis of skin disorders, thus hampering the growth of the teledermatology market over the forecast period.

Opportunities:

According to a study, physicians receive lesser reimbursement for teledermatology visits because teledermatology reduces visit costs by $10–$80 when compared to in-person consultations. Before COVID-19, insurance companies paid less for teledermatology visits than for in-person visits. To encourage physicians to practice teledermatology during COVID-19, insurance companies have begun to provide payment parity for teledermatology appointments while keeping physician salaries the same.

The adoption of artificial intelligence is one of the key trends in teledermatology. Healthcare organizations are rapidly expanding telemedicine programs and embracing long-distance consultations. Through teledermatology, new developments in deep learning, a type of artificial intelligence (AI), have been utilized to diagnose cases of melanoma from lesion images. In the coming decade, the smartphone industry estimates that next-generation devices and widespread adoption will put deep learning-capable hardware in the hands of consumers all around the world thereby, creating opportunities for market players.

Market Segmentation

By type, the service segment is expected to lead the teledermatology market in the projected period. Teledermatology offers numerous services such as teleconsultation, telemonitoring, and tele-education. Teleconsultation has reduced the waiting time for patients. The well-developed telecom sector and 4G band spectrum have promoted individuals to adopt teleconsulting services. According to the Merritt Hawkins Survey, the average waiting time for a consultation has increased from 28.8 days in 2014 to 32.2 days in 2017 in the US, attributed to the dermatologist shortage. As a result, there has been an increase in the adoption of virtual visits in several hospitals thus, strengthening the service segment.

By modality, the store and forward (SAF) segment is anticipated to have the largest share of the teledermatology market over the forecast period. SAF is most widely utilized in teledermatology. It involves taking pictures and videos, which are subsequently evaluated by a dermatologist at different times and places. This procedure is relatively affordable because it does not require any interaction between the patient and the physician. It is especially well suited for those with limited access to health care as no scheduled visits are required. Additionally, it can be utilized across different time zones, for instance, a patient in India can get advice from a dermatologist in America without having an impact on daily activities.

By end-users, the homecare segment is forecasted to dominate the teledermatology market attributed to the highly developed telecom and IT sector. Homecare offers advantages such as cost savings, convenience, and the ability to provide care to individuals with mobility limitations or those living in remote areas without access to a local doctor or clinic. According to a Harvard report, in 2020 76 percent of hospitals in the United States utilized telehealth services to connect doctors and patients remotely, up from 35 percent a decade ago. Additionally, one in every four Americans over the age of 50 reported they had a virtual health care visit during the first three months of the pandemic, up from 4% of older individuals who had a remote visit the year before.

Players Covered in Teledermatology market are :

• 3Gen Consulting (US)
• FirstDerm (US)
• MetaOptima (Canada)
• MDLIVE Inc. (US)
• VigNet Inc. (US)
• Ping An Healthcare and Technology Company Limited (China)
• Maple (Canada)
• Ksyos (Netherlands)
• CureSkin (India)
• 3Derm (U.S.) and others major players.

Regional Analysis of Teledermatology Market:

The North American region is anticipated to have the highest share of the teledermatology market during the forecast period. Skin cancer is the most often diagnosed cancer in the United States, however, only 1% of cases turn out to have invasive melanoma. The number of newly diagnosed melanoma cases in the United States was estimated to be 91,270 in 2018. It is estimated that 9,320 people will die as a result of this disease. Melanoma is responsible for the majority of cancer-related deaths; however, it can be entirely cured in most cases if discovered early and treated properly. Teledermatology can play a vital role in diagnosing cancer as well as offer remote treatment to individuals lacking healthcare infrastructure. Government support, the presence of prominent service providers, and a rise in teleconsultations are the major factors driving the growth of the teledermatology market in this region.

The European region is expected to have the second-highest share of the teledermatology market. European countries are highly advanced, which has resulted in an inclination towards telemedicine services. Countries with the lowest number of dermatologists per million people and dermatologists who work largely in the public sector rather than private practice, such as Spain, the Netherlands, and the United Kingdom, have significantly more experience with teledermatology and have significant established mass digital services. In the United Kingdom, national surveys found that active engagement in teledermatology increased from 17% in 2006 to 48% in 2016, and dermatologists with any experience with teledermatology increased from 27% to 82% within the same period. The COVID-19 pandemic forced both healthcare professionals as well as patients to adopt teledermatology services thus, strengthening the growth of the market.

The teledermatology market in the Asia-Pacific region is anticipated to develop at the highest CAGR during the forecast period attributed to the rise in the number of service providers. For instance, individuals living in rural regions of India have limited access to healthcare services. Moreover, most individuals seeking medical advice go to their primary care physicians (PCPs) first. However, they lack the knowledge as well as equipment required for proper diagnosing of skin disease. Teledermatology can bridge this gap by allowing individuals to seek medical advice from a dermatologist as well help PCP to connect with a dermatologist regarding specific cases. The growing usage of smartphones and availability of internet services at a cheap rate is supporting the growth of the teledermatology market in this region.

Recent Industry Developments in Teledermatology Market:

• In October 2023, NHS boards across the UK are implementing revolutionary teledermatology technology that allows General Practitioners (GPs) to quickly obtain specialist advice from consultant dermatologists. This system enables GPs to capture, store, and forward photos and files directly to NHS dermatology experts for pre-referral guidance. Consultant Connect’s PhotoSAF platform, the UK’s most widely used teledermatology service, is now utilized by over 3,500 NHS organizations, including GP practices and Trusts, covering more than half of the NHS across England, Scotland, and Wales.

COVID-19 Impact on Teledermatology Market:

The COVID-19 pandemic has completely changed the face of dermatology care. Teledermatology has emerged as a powerful tool for delivering remote care in an age of lockdowns and social distancing. The teledermatology field has rapidly developed as a result of the lockdown imposed to constrain the spread of the coronavirus disease. It has enabled dermatologists to deliver dermatological care remotely, reducing the risk of COVID-19 transmission in inpatient settings. In June 2020, Elsner studied the utilization of teledermatology during the COVID-19 days. Overall, the review found a higher dependence on teledermatology during the pandemic, as well as positive attitudes toward this novel type of care. teledermatology reduces travel costs for patients and removes time spent traveling to a doctor's office by providing at-home care. In addition to lower travel expenses, a 2019 study in Philadelphia found that teledermatology lowers medical costs for patients by reducing urgent care and emergency department visits due to timely access to care provided by teledermatology. To summarize, the COVID-19 pandemic has boosted the usage of teledermatology services.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Data Transmission
 3.3 By End-Users

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Teledermatology Market by Type
 5.1 Teledermatology Market Overview Snapshot and Growth Engine
 5.2 Teledermatology Market Overview
 5.3 Products
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Products: Grographic Segmentation
 5.4 Services {Teleconsultation
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Services {Teleconsultation: Grographic Segmentation
 5.5 Telemonitoring
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Telemonitoring: Grographic Segmentation
 5.6 Tele-Education
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Tele-Education: Grographic Segmentation
 5.7 Others}
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others}: Grographic Segmentation

Chapter 6: Teledermatology Market by Data Transmission
 6.1 Teledermatology Market Overview Snapshot and Growth Engine
 6.2 Teledermatology Market Overview
 6.3 Store & Forward {Asynchronous}
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Store & Forward {Asynchronous}: Grographic Segmentation
 6.4 Real-Time {Synchronous}
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Real-Time {Synchronous}: Grographic Segmentation
 6.5 Hybrid
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Hybrid: Grographic Segmentation

Chapter 7: Teledermatology Market by End-Users
 7.1 Teledermatology Market Overview Snapshot and Growth Engine
 7.2 Teledermatology Market Overview
 7.3 Healthcare Facilities
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Healthcare Facilities: Grographic Segmentation
 7.4 Homecare
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Homecare: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Teledermatology Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Teledermatology Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Teledermatology Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 3GEN CONSULTING
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 FIRSTDERM
 8.4 METAOPTIMA
 8.5 MDLIVE INC.
 8.6 VIGNET INC.
 8.7 PING AN HEALTHCARE & TECHNOLOGY COMPANY LIMITED
 8.8 MAPLE
 8.9 KSYOS
 8.10 CURESKIN
 8.11 3DERM
 8.12 OTHER MAJOR PLAYERS

Chapter 9: Global Teledermatology Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Products
  9.2.2 Services {Teleconsultation
  9.2.3 Telemonitoring
  9.2.4 Tele-Education
  9.2.5 Others}
 9.3 Historic and Forecasted Market Size By Data Transmission
  9.3.1 Store & Forward {Asynchronous}
  9.3.2 Real-Time {Synchronous}
  9.3.3 Hybrid
 9.4 Historic and Forecasted Market Size By End-Users
  9.4.1 Healthcare Facilities
  9.4.2 Homecare

Chapter 10: North America Teledermatology Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Products
  10.4.2 Services {Teleconsultation
  10.4.3 Telemonitoring
  10.4.4 Tele-Education
  10.4.5 Others}
 10.5 Historic and Forecasted Market Size By Data Transmission
  10.5.1 Store & Forward {Asynchronous}
  10.5.2 Real-Time {Synchronous}
  10.5.3 Hybrid
 10.6 Historic and Forecasted Market Size By End-Users
  10.6.1 Healthcare Facilities
  10.6.2 Homecare
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Teledermatology Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Products
  11.4.2 Services {Teleconsultation
  11.4.3 Telemonitoring
  11.4.4 Tele-Education
  11.4.5 Others}
 11.5 Historic and Forecasted Market Size By Data Transmission
  11.5.1 Store & Forward {Asynchronous}
  11.5.2 Real-Time {Synchronous}
  11.5.3 Hybrid
 11.6 Historic and Forecasted Market Size By End-Users
  11.6.1 Healthcare Facilities
  11.6.2 Homecare
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Teledermatology Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Products
  12.4.2 Services {Teleconsultation
  12.4.3 Telemonitoring
  12.4.4 Tele-Education
  12.4.5 Others}
 12.5 Historic and Forecasted Market Size By Data Transmission
  12.5.1 Store & Forward {Asynchronous}
  12.5.2 Real-Time {Synchronous}
  12.5.3 Hybrid
 12.6 Historic and Forecasted Market Size By End-Users
  12.6.1 Healthcare Facilities
  12.6.2 Homecare
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Teledermatology Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Products
  13.4.2 Services {Teleconsultation
  13.4.3 Telemonitoring
  13.4.4 Tele-Education
  13.4.5 Others}
 13.5 Historic and Forecasted Market Size By Data Transmission
  13.5.1 Store & Forward {Asynchronous}
  13.5.2 Real-Time {Synchronous}
  13.5.3 Hybrid
 13.6 Historic and Forecasted Market Size By End-Users
  13.6.1 Healthcare Facilities
  13.6.2 Homecare
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Teledermatology Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Products
  14.4.2 Services {Teleconsultation
  14.4.3 Telemonitoring
  14.4.4 Tele-Education
  14.4.5 Others}
 14.5 Historic and Forecasted Market Size By Data Transmission
  14.5.1 Store & Forward {Asynchronous}
  14.5.2 Real-Time {Synchronous}
  14.5.3 Hybrid
 14.6 Historic and Forecasted Market Size By End-Users
  14.6.1 Healthcare Facilities
  14.6.2 Homecare
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. TELEDERMATOLOGY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. TELEDERMATOLOGY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. TELEDERMATOLOGY MARKET COMPETITIVE RIVALRY
TABLE 005. TELEDERMATOLOGY MARKET THREAT OF NEW ENTRANTS
TABLE 006. TELEDERMATOLOGY MARKET THREAT OF SUBSTITUTES
TABLE 007. TELEDERMATOLOGY MARKET BY TYPE
TABLE 008. PRODUCTS MARKET OVERVIEW (2016-2028)
TABLE 009. SERVICES {TELECONSULTATION MARKET OVERVIEW (2016-2028)
TABLE 010. TELEMONITORING MARKET OVERVIEW (2016-2028)
TABLE 011. TELE-EDUCATION MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS} MARKET OVERVIEW (2016-2028)
TABLE 013. TELEDERMATOLOGY MARKET BY DATA TRANSMISSION
TABLE 014. STORE & FORWARD {ASYNCHRONOUS} MARKET OVERVIEW (2016-2028)
TABLE 015. REAL-TIME {SYNCHRONOUS} MARKET OVERVIEW (2016-2028)
TABLE 016. HYBRID MARKET OVERVIEW (2016-2028)
TABLE 017. TELEDERMATOLOGY MARKET BY END-USERS
TABLE 018. HEALTHCARE FACILITIES MARKET OVERVIEW (2016-2028)
TABLE 019. HOMECARE MARKET OVERVIEW (2016-2028)
TABLE 020. NORTH AMERICA TELEDERMATOLOGY MARKET, BY TYPE (2016-2028)
TABLE 021. NORTH AMERICA TELEDERMATOLOGY MARKET, BY DATA TRANSMISSION (2016-2028)
TABLE 022. NORTH AMERICA TELEDERMATOLOGY MARKET, BY END-USERS (2016-2028)
TABLE 023. N TELEDERMATOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 024. EUROPE TELEDERMATOLOGY MARKET, BY TYPE (2016-2028)
TABLE 025. EUROPE TELEDERMATOLOGY MARKET, BY DATA TRANSMISSION (2016-2028)
TABLE 026. EUROPE TELEDERMATOLOGY MARKET, BY END-USERS (2016-2028)
TABLE 027. TELEDERMATOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 028. ASIA PACIFIC TELEDERMATOLOGY MARKET, BY TYPE (2016-2028)
TABLE 029. ASIA PACIFIC TELEDERMATOLOGY MARKET, BY DATA TRANSMISSION (2016-2028)
TABLE 030. ASIA PACIFIC TELEDERMATOLOGY MARKET, BY END-USERS (2016-2028)
TABLE 031. TELEDERMATOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 032. MIDDLE EAST & AFRICA TELEDERMATOLOGY MARKET, BY TYPE (2016-2028)
TABLE 033. MIDDLE EAST & AFRICA TELEDERMATOLOGY MARKET, BY DATA TRANSMISSION (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA TELEDERMATOLOGY MARKET, BY END-USERS (2016-2028)
TABLE 035. TELEDERMATOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 036. SOUTH AMERICA TELEDERMATOLOGY MARKET, BY TYPE (2016-2028)
TABLE 037. SOUTH AMERICA TELEDERMATOLOGY MARKET, BY DATA TRANSMISSION (2016-2028)
TABLE 038. SOUTH AMERICA TELEDERMATOLOGY MARKET, BY END-USERS (2016-2028)
TABLE 039. TELEDERMATOLOGY MARKET, BY COUNTRY (2016-2028)
TABLE 040. 3GEN CONSULTING: SNAPSHOT
TABLE 041. 3GEN CONSULTING: BUSINESS PERFORMANCE
TABLE 042. 3GEN CONSULTING: PRODUCT PORTFOLIO
TABLE 043. 3GEN CONSULTING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. FIRSTDERM: SNAPSHOT
TABLE 044. FIRSTDERM: BUSINESS PERFORMANCE
TABLE 045. FIRSTDERM: PRODUCT PORTFOLIO
TABLE 046. FIRSTDERM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. METAOPTIMA: SNAPSHOT
TABLE 047. METAOPTIMA: BUSINESS PERFORMANCE
TABLE 048. METAOPTIMA: PRODUCT PORTFOLIO
TABLE 049. METAOPTIMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. MDLIVE INC.: SNAPSHOT
TABLE 050. MDLIVE INC.: BUSINESS PERFORMANCE
TABLE 051. MDLIVE INC.: PRODUCT PORTFOLIO
TABLE 052. MDLIVE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. VIGNET INC.: SNAPSHOT
TABLE 053. VIGNET INC.: BUSINESS PERFORMANCE
TABLE 054. VIGNET INC.: PRODUCT PORTFOLIO
TABLE 055. VIGNET INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. PING AN HEALTHCARE & TECHNOLOGY COMPANY LIMITED: SNAPSHOT
TABLE 056. PING AN HEALTHCARE & TECHNOLOGY COMPANY LIMITED: BUSINESS PERFORMANCE
TABLE 057. PING AN HEALTHCARE & TECHNOLOGY COMPANY LIMITED: PRODUCT PORTFOLIO
TABLE 058. PING AN HEALTHCARE & TECHNOLOGY COMPANY LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. MAPLE: SNAPSHOT
TABLE 059. MAPLE: BUSINESS PERFORMANCE
TABLE 060. MAPLE: PRODUCT PORTFOLIO
TABLE 061. MAPLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. KSYOS: SNAPSHOT
TABLE 062. KSYOS: BUSINESS PERFORMANCE
TABLE 063. KSYOS: PRODUCT PORTFOLIO
TABLE 064. KSYOS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. CURESKIN: SNAPSHOT
TABLE 065. CURESKIN: BUSINESS PERFORMANCE
TABLE 066. CURESKIN: PRODUCT PORTFOLIO
TABLE 067. CURESKIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. 3DERM: SNAPSHOT
TABLE 068. 3DERM: BUSINESS PERFORMANCE
TABLE 069. 3DERM: PRODUCT PORTFOLIO
TABLE 070. 3DERM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 071. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 072. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 073. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. TELEDERMATOLOGY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. TELEDERMATOLOGY MARKET OVERVIEW BY TYPE
FIGURE 012. PRODUCTS MARKET OVERVIEW (2016-2028)
FIGURE 013. SERVICES {TELECONSULTATION MARKET OVERVIEW (2016-2028)
FIGURE 014. TELEMONITORING MARKET OVERVIEW (2016-2028)
FIGURE 015. TELE-EDUCATION MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS} MARKET OVERVIEW (2016-2028)
FIGURE 017. TELEDERMATOLOGY MARKET OVERVIEW BY DATA TRANSMISSION
FIGURE 018. STORE & FORWARD {ASYNCHRONOUS} MARKET OVERVIEW (2016-2028)
FIGURE 019. REAL-TIME {SYNCHRONOUS} MARKET OVERVIEW (2016-2028)
FIGURE 020. HYBRID MARKET OVERVIEW (2016-2028)
FIGURE 021. TELEDERMATOLOGY MARKET OVERVIEW BY END-USERS
FIGURE 022. HEALTHCARE FACILITIES MARKET OVERVIEW (2016-2028)
FIGURE 023. HOMECARE MARKET OVERVIEW (2016-2028)
FIGURE 024. NORTH AMERICA TELEDERMATOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. EUROPE TELEDERMATOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. ASIA PACIFIC TELEDERMATOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. MIDDLE EAST & AFRICA TELEDERMATOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. SOUTH AMERICA TELEDERMATOLOGY MARKET OVERVIEW BY COUNTRY (2016-2028)